Julie Maring
Medical · Grand Rapids, MINPI 1104845510
Payments from drug & device makers
Across 158 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$414
- Pharmacyclics LLC, An Abbvie Company$280
- AbbVie$232
- Sanofi$207
- GSK$201
- Novartis$186
- plus $1K from 29 others
What the payments were for
- Food & beverage$2,92199%
- Education$231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 37 | $414 |
| Pharmacyclics LLC, An Abbvie Company | 11 | $280 |
| AbbVie | 12 | $232 |
| Sanofi | 10 | $207 |
| GSK | 11 | $201 |
| Novartis | 10 | $186 |
| Gilead(2 entities) | 8 | $168 |
| Genentech USA, Inc. | 6 | $149 |
| AstraZeneca | 6 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $89 |
| Amneal Pharmaceuticals LLC | 3 | $75 |
| Ipsen Biopharmaceuticals, Inc | 3 | $71 |
| Eisai Inc. | 3 | $68 |
| Pfizer | 4 | $66 |
| Johnson & Johnson | 2 | $53 |
| Astellas Pharma US Inc | 2 | $50 |
| Adaptive Biotechnologies Corporation | 2 | $48 |
| Daiichi Sankyo Inc. | 2 | $41 |
| Alnylam Pharmaceuticals Inc. | 2 | $39 |
| Jazz Pharmaceuticals Inc. | 2 | $39 |
| Incyte Corporation | 2 | $38 |
| Merck | 1 | $35 |
| Beigene USA, Inc. | 1 | $33 |
| ADC Therapeutics America, Inc. | 2 | $32 |
| Lilly USA, LLC | 2 | $30 |
| Genmab U.S., Inc. | 1 | $27 |
| Progenics Pharmaceuticals, Inc. | 1 | $25 |
| Karyopharm Therapeutics Inc. | 1 | $21 |
| Springworks Therapeutics, Inc. | 1 | $19 |
| Morphosys, US Inc. | 1 | $18 |
| Myovant Sciences Inc. | 1 | $17 |
| G1 Therapeutics, Inc. | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $16 |
| EMD Serono, Inc. | 1 | $15 |
| Foundation Medicine, Inc. | 1 | $12 |
How this compares
$2,944 in reported general payments places this provider in the 80th percentile of 755 medical providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acyclovir | 66 | $1,175 |
| Hydroxyurea | 23 | $410 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $223 |
| Allopurinol | 19 | $195 |
| Gabapentin | 19 | $164 |
Paid to pharmacies, not to this prescriber.
Other medical in Grand Rapids
- Meredith KentGrand Rapids$192K
- David BarneyGrand Rapids$21K
- Nisha McKenzieGrand Rapids$19K
- Brenda WhartonGrand Rapids$11K
- Andra TalaskaGrand Rapids$11K
- Jennifer DykhouseGrand Rapids$8K
- Evan GerondaleGrand Rapids$7K
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Amber ShullNorton Shores$154K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.